safety and efficacy profile of tisotumab vedotin for recurrent or metastatic cervical cancer
Published 2 years ago • 258 plays • Length 4:44Download video MP4
Download video MP3
Similar videos
-
1:24
evaluating next steps for tisotumab vedotin in recurrent or metastatic cervical cancer
-
1:45
dr. hong on the safety profile of tisatumab vedotin in cervical cancer
-
2:10
highlights on tisotumab vedotin 2l or 3l recurrent or metastatic cervical cancer: innovatv 301
-
4:58
tisotumab vedotin for metastatic cervical cancer: results from esmo 2023 with brian slomovitz, md
-
1:41
investigating combinations in recurrent or metastatic cervical cancer
-
1:10
results for tisotumab vedotin in patients with metastatic or recurrent cervical cancer
-
0:57
dr. monk on the utility of tisotumab vedotin in recurrent cervical cancer
-
2:47
tisotumab vedotin shows clinically meaningful os improvement versus chemo for metastatic cervica...
-
0:55
dr. monk on the mechanism of action of tisotumab vedotin in recurrent cervical cancer
-
0:30
treatment options for recurrent cervical cancer | premal thaker, md, ms | asco22 gyn cancer updates
-
0:47
”as a cervical cancer patient, what results can i expect from the drug tisotumab vedotin?"
-
3:48
gynecologic oncology at esmo congress 2021: engot-cx8/gog-3024/innovatv 205 study
-
2:53
the innovatv 301 trial
-
1:45
dr. coleman on the clinical implications of the innovatv 204 trial in cervical cancer
-
8:52
frontline therapies for metastatic cervical cancer
-
1:00
how i learned i had cervical cancer!
-
1:00
chronic conditions - understanding cervical cancer | #shorts
-
2:46
the innovatv 301 trial
-
1:26:22
combos are complicated! navigating the balance of efficacy and safety in advanced endometrial cancer